June 9 (Reuters) - Immuron Ltd (IMC) :
- US DOD NAVAL MEDICAL RESEARCH CENTER REQUESTS MEETING WITH FDA FOR GUIDANCE ON TWO PHASE 2 TRIALS TO PREVENT ACUTE INFECTIOUS DIARRHEA
- IMMURON LTD - TWO HUMAN PHASE II CLINICAL TRIALS TO BE CONDUCTED IN 2021
- IMMURON - ONE TRIAL TO FOCUS ON ABILITY OF HYPERIMMUNE PRODUCT TO PROTECT VOLUNTEERS AGAINST MODERATE TO SEVERE CAMPYLOBACTERIOSIS
- IMMURON - SECOND TRIAL WILL FOCUS ON ETEC INFECTIONS
- IMMURON LTD - NMRC PLANS TO FILE IND APPLICATION LATER THIS YEAR, COMMENCE PHASE 2 CLINICAL STUDIES DURING H1 2021
News: IMC Immuron Says US DOD Naval Medical Research Center Requests Meeting With FDA On Two Phase...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.013(14.1%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.8¢ | $41.97K | 418.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43600 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 149018 | 6 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMC (ASX) Chart |